Ocuphire Pharma Inc.

05/18/2021 | Press release | Distributed by Public on 05/18/2021 05:30

Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia